Tomoko Mineyama

A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers

N. Shimada, M. Woo, Asuka Yamamoto, 2013, International Journal of Hematology.